| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442071 | European Journal of Cancer | 2015 | 9 Pages |
Abstract
Denosumab treatment was more efficacious than treatment with zoledronic acid in delaying or preventing HCM in advanced cancer patients with breast cancer, other solid tumours or multiple myeloma.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ingo J. Diel, Jean-Jacques Body, Alison T. Stopeck, Saroj Vadhan-Raj, Andrew Spencer, Günther Steger, Roger von Moos, François Goldwasser, Amy Feng, Ada Braun,